OnTracka

OnTracka OnTracka is a data-driven well-being tool that accelerates our understanding of the endless possib The available platforms include:

1.

Our ideology is based on a belief that opportunities should be available for you to experience transformational coaching programs in world-class locations. At Inflow, we create personalised life-changing experiences by using an expert coaching method that helps you to optimise your health, happiness, relationships and career. Inflow Health Escapes – Our escapes are like nothing else. They are more akin to a modern retreat but they have the added options of having access to our team of doctors, the access to a range of recovery equipment at a world-class recovery facility, an expert coaching model to support your psychology and emotional health, recreational options that vary pending on the location and your interests, available strength and conditioning training, a nutrition plan that covers for ketogenic, paleo or plant based diets and a yoga, meditation and breathing program that is tailored for each individual. Our health escapes are an immersive life-changing experience for small and intimate groups or for exclusive personalised health escapes that will meet all your health and travel needs.

2. Personalised Coaching Programs - Our expert coaching model has been evolving for over 13 years in directly supporting people to optimise their physical, emotional and psychological well-being.

3. Business Solutions - We incorporate our expert coaching knowledge and our tailored Health Escapes into businesses and organisations to promote the health, happiness, fulfilment and performance of the employees.

4. Events – We deliver a range specialist workshops and events to support the health and connectivity of individuals around the world.

21/02/2026

On the road to presenting world-first real-world evidence at .

OnTracka Founder & CEO   will be in Australia (Sydney and Brisbane) to present a world-first dataset on Aboriginal healt...
19/02/2026

OnTracka Founder & CEO will be in Australia (Sydney and Brisbane) to present a world-first dataset on Aboriginal health outcomes with medical cannabis at UIC 2026.

At the same conference, the From Dose to Decision-Making white paper, published last year as part of the OnTracka Research Initiative, The Health Collective, will also be presented by Lead Author Mark Gannot. This marks a significant milestone and expanded presence for OnTracka at UIC 2026.

During this visit, Chad will be available for meetings in Sydney from 23–25 Feb and in Brisbane from 25–28 Feb.

If you’re interested in connecting around data capture, evidence generation, or clinical trial enablement, check link in bio to register interest.

You may see headlines suggesting canna compounds outperform cancer drugs.The reality is more measured.This was a computa...
17/02/2026

You may see headlines suggesting canna compounds outperform cancer drugs.

The reality is more measured.

This was a computational modelling study. A legitimate and important first step, but still far from clinical application. We break down what was done, what it suggests, and what it does not prove. Evidence matters most when the claims are bold.

2026 marks ten years since medicinal canna was legalised in Australia.Astrid’s 10 Year Series is reflecting on how far t...
12/02/2026

2026 marks ten years since medicinal canna was legalised in Australia.

Astrid’s 10 Year Series is reflecting on how far the industry has come and where it’s headed next.

Our CEO, shares his perspective on building in a space that needed evidence, infrastructure, and long-term thinking.

The first decade shaped the foundations. The next will define the standards.

Read the full feature via the link in bio.

You’ve probably seen the recent headlines claiming canna improves brain health.We are not saying it doesn’t.We are sayin...
10/02/2026

You’ve probably seen the recent headlines claiming canna improves brain health.

We are not saying it doesn’t.

We are saying the research is far more nuanced, and we’ve broken down the study to show what the data actually says.

Honoured to share the stage with some of the world's leading researchers in cannabis medicine at this year's AMCA UIC Co...
05/02/2026

Honoured to share the stage with some of the world's leading researchers in cannabis medicine at this year's AMCA UIC Conference.

I'll be presenting on a subject matter that has been completely void in the industry and one we'll share more about in the lead up to the conference.

For now, mark it in your calendar 👇
📅 Thursday 26 Feb
⏰ 2:30pm
📍 Hall B

New laws to support removed scrutiny for patient to access via Telehealth. But, MC continues to face disproportionate sc...
04/02/2026

New laws to support removed scrutiny for patient to access via Telehealth. But, MC continues to face disproportionate scrutiny.

An interview with OnTracka Founder  is published in  by Bee Mohamed where he talks about purpose, patient trust, and ret...
02/02/2026

An interview with OnTracka Founder is published in by Bee Mohamed where he talks about purpose, patient trust, and rethinking how healthcare evidence is built.

👀Full interview in bio

30/01/2026

Watch this video over the weekend and see if you agree with us.

Wait... you've been inhaling OIL DROPLETS this whole time?  New research from the lab is changing what we know about can...
28/01/2026

Wait... you've been inhaling OIL DROPLETS this whole time? New research from the lab is changing what we know about cannabis consumption. Tap through to see what surprised us most.

Across our latest OnTracka patient reports, patients  in complex mental health care are completing structured dose sessi...
21/01/2026

Across our latest OnTracka patient reports, patients in complex mental health care are completing structured dose sessions more than asked in the patient treatment plans.

This means, they are engaging in their digital health treatment via OnTracka not because they’re told to, but because they want to.

Federal policy around psychedelics is shifting fast.With record increases in legal production quotas for psilocybin, psi...
20/01/2026

Federal policy around psychedelics is shifting fast.
With record increases in legal production quotas for psilocybin, psilocin and DMT, 2026 is shaping up to be a pivotal year for psychedelic research.
These numbers reflect growing scientific demand and a changing regulatory mindset.

Address

Dee Why, NSW

Alerts

Be the first to know and let us send you an email when OnTracka posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to OnTracka:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram